Melatonin extended-release vs regular: which to choose

On the shelf with sleep aids, two items that look similar stand side by side, but have different data behind them: regular melatonin and extended-release melatonin. The difference is not in strength, but in the release profile, which determines what sleep problem the product was studied for. Additionally, there is something rarely mentioned: in Poland, melatonin can be a dietary supplement, an over-the-counter medication, and in extended-release form, it is a prescription medication. This article clarifies both: it shows what sleep problem each form was studied for, what dosage has data behind it, and what is purely a marketing decision, and finally lists what is actually available in the u Bucha store, in what legal status and at what price per serving.

KEY INFORMATION
• The health claim about shortening the time to fall asleep refers to 1 mg of melatonin taken close to bedtime, not doses of 5 or 10 mg (EFSA, 2011).
• The regular form has data for falling asleep and jet lag; the extended-release form was studied for sleep quality in people over 55 (Lemoine, 2007).
• In jet lag, 2 mg of slow-release melatonin proved relatively ineffective, suggesting that a short, high peak matters (Herxheimer and Petrie, 2002).
• Extended-release melatonin 2 mg is a prescription medication in Poland, not a dietary supplement.
• All melatonin products available in the store are dietary supplements in regular form, gummies declare 1 mg per serving.

What is melatonin and how does it affect sleep?

Melatonin is a hormone whose production is triggered by darkness and inhibited by light. Its role is to signal the biological clock in the suprachiasmatic nuclei of the hypothalamus that night is beginning, and to activate the body's night mode, from sleep to nighttime blood pressure and metabolism profile (Zisapel, Br J Pharmacol, 2018). It is a signal of time, not a sleep aid in the classical sense.

This leads to a practical consequence. The most evident effects of melatonin are seen in disorders where its own rhythm is weakened or shifted: in circadian rhythm disorders, with jet lag and shift work, and with non-restorative sleep. Where the rhythm is fine, but sleep is disrupted by something else, melatonin itself changes little.

The scale of the effect is also moderate. A meta-analysis of seventeen studies involving 284 people showed a reduction in sleep onset time by 4.0 minutes, an increase in sleep efficiency by 2.2 percent, and an extension of sleep by 12.8 minutes (Brzezinski i wsp., Sleep Med Rev, 2005). These are real numbers, but far from the promise suggested by the packaging.

The molecule in both forms compared here is identical. They differ only in how quickly and how long they are released, and thus how the concentration curve looks after taking the preparation (Tordjman i wsp., Curr Neuropharmacol, 2017).

What is the difference between regular melatonin and extended-release melatonin?

The regular form provides a quick and short-lived peak in concentration. The extended-release form spreads the release over time to mimic the nightly profile of endogenous secretion. This difference is not cosmetic: it affects the studies in which each form performed well and at what time it makes sense to take it.

The last row of the table is the one that often gets overlooked. The choice between forms is not a choice between two products on the same shelf in Poland, as the extended-release form at a dose of 2 mg requires a prescription.

Does a higher dose of melatonin work better?

There is no data on this, and there are several arguments against it. In a randomized, placebo-controlled study, fifteen people over fifty with confirmed decreased sleep efficiency and fifteen normally sleeping individuals received 0.1 mg, 0.3 mg, and 3.0 mg of melatonin 30 minutes before sleep for a week (Zhdanova i wsp., J Clin Endocrinol Metab, 2001). The physiological dose of 0.3 mg restored sleep efficiency while simultaneously raising melatonin levels in the blood to the normal nighttime range.

The pharmacological dose of 3.0 mg also improved sleep but caused hypothermia and maintained elevated melatonin levels into daytime hours. In normally sleeping individuals, none of the doses changed sleep, even though they also had low levels of endogenous melatonin.

The regulator set the threshold similarly low. A health claim about reducing the time needed to fall asleep requires 1 mg of melatonin taken close to bedtime (EFSA Journal 2011;9(6):2241), and a separate claim about alleviating jet lag requires 0.5 mg (EFSA Journal 2010;8(2):1467). The Cochrane review adds that doses above 5 mg did not work better than lower doses for jet lag. Therefore, preparations of 10 mg have no support in studies on sleep onset or in approved claims.

When is regular melatonin a better choice?

When the problem is simply falling asleep or a shifted clock. This is the only form to which the approved claim about reducing the time needed to fall asleep at 1 mg per dose applies.

However, the strongest data comes from jet lag. The Cochrane review included ten randomized studies, of which nine showed that melatonin taken close to the target bedtime, between 10 PM and midnight, reduces jet lag after flying through five or more time zones (Herxheimer i Petrie, Cochrane Database Syst Rev, 2002). The number of people that need to be treated to achieve one additional effect was 2. The benefit increases with the number of time zones crossed and is smaller for westward flights. The authors add a warning: taking the supplement at the wrong time, early in the day, causes drowsiness and delays adaptation to local time.

The third area is circadian rhythm disorders. The guidelines from the American Academy of Sleep Medicine support appropriately timed melatonin in delayed sleep phase syndrome, in blind adults with a rhythm different from the daily cycle, and in children and adolescents with irregular rhythms and neurological disorders (Auger i wsp., J Clin Sleep Med, 2015). The same guidelines advise against melatonin in older adults with dementia.

When to choose extended-release melatonin?

This form has one well-researched application, and it is narrow. In a multicenter randomized placebo-controlled trial, 170 outpatient patients with primary insomnia aged 55 and older took extended-release melatonin at a dose of 2 mg for three weeks (Lemoine i wsp., J Sleep Res, 2007). Sleep quality and morning alertness improved, and both improvements were strongly correlated, which the authors interpret as an increase in the restorative value of sleep.

After discontinuation, there was no rebound insomnia or withdrawal symptoms, and the incidence of adverse events was low and mostly mild. This is a reasonable argument for someone who wakes up feeling unrefreshed despite a full night’s sleep.

However, the decision does not rest with the buyer. The product characteristics of Circadin describe it as a monotherapy for the short-term treatment of primary insomnia with poor sleep quality in patients aged 55 and older, at a dose of 2 mg once daily, 1 to 2 hours before bedtime, after a meal, for a period of up to thirteen weeks. The product is prescription-only. Separately, it is worth noting that for jet lag, the slow release of 2 mg performed relatively poorly in the Cochrane review, so the advantage of this form does not carry over to travel.

Czy melatonina to lek, czy suplement diety?

In Poland, both are available, and it is the same molecule. Some melatonin products are registered as prescription-only medicinal products, with product characteristics and leaflets approved by the registration office. Some are dietary supplements, meaning food reported to the health authorities. The extended-release form at a dose of 2 mg is a prescription medication.

This difference has practical implications and is not just about the prestige of the packaging. A dietary supplement has no registered indication and cannot be presented as treating insomnia. It can only use approved health claims, such as reducing the time needed to fall asleep at 1 mg per serving and alleviating jet lag at 0.5 mg.

The reverse direction is equally important. The results of the Lemoine study pertain to a specific medicinal product with a defined release profile and do not automatically transfer to a gummy with the same number of milligrams, as the release profile was the variable studied in this research. Therefore, when reading the packaging, check two things: whether it states medicinal product or dietary supplement and how much melatonin is in one serving.

What melatonin products are available at u Bucha?

It is worth stating clearly what is not available in the offer. There are no extended-release tablets or any melatonin product classified as a medicinal product, as the former category requires a prescription. Everything that is available are dietary supplements in standard form, intended for adults.

Four items declare exactly 1 mg of melatonin per serving, which is the amount required for the approved claim about reducing the time to fall asleep. Two shots list melatonin in the ingredient list but do not specify its amount per serving, so the exact content must be read from the bottle label. The cost per serving column converts the price to one use, as the prices of packages with different numbers of servings do not allow for comparison.

Prices are from the store and are current as of August 8, 2026. You can find the first four items in the category jelly candy, dwie ostatnie w kategorii shots.

What are the interactions and limitations of melatonin?

The best-documented interaction concerns fluvoxamine. Five healthy volunteers took 5 mg of melatonin once alone and once together with 50 mg of fluvoxamine; the combined administration resulted in an average of seventeen times higher melatonin concentration in serum, not due to increased production, but due to the inhibition of its elimination (Härtter i wsp., Clin Pharmacol Ther, 2000). The study was small, but the effect was significant enough that melatonin should be discussed with a doctor when using this medication.

The Cochrane review notes two signals from case descriptions: the potential for harm in individuals with epilepsy and in patients taking warfarin. The frequency of other adverse effects is described as low.

Data on the safety of short-term use is reassuring. A meta-analysis from 2005 found no evidence of adverse effects from melatonin and deemed it safe for use for three months or less (Buscemi i wsp., J Gen Intern Med, 2005). There is a lack of such data for longer use. Manufacturers of melatonin supplements in the store recommend them exclusively for adults and advise against use by pregnant or breastfeeding women.

What to do if melatonin doesn't help?

Start by asking whether melatonin is even suitable for this problem. The same meta-analysis shows a reduction in sleep onset time by 11.7 minutes across the group, but the distribution of this effect is uneven: 38.8 minutes in the delayed sleep phase syndrome group compared to 7.2 minutes in insomnia. Melatonin works best where the clock is shifted, not everywhere sleep is poor.

The second thing is timing, not dosage. The Cochrane review directly links effectiveness to taking the preparation close to the target sleep time and warns that taking it early reverses the effect.

If that is not enough, there are two supplement pathways with data. L-theanine at a dose of 400 mg daily for six weeks increased sleep percentage and its effectiveness in boys with attention deficit hyperactivity disorder, but did not change sleep onset time (Lyon i wsp., Altern Med Rev, 2011). Ashwagandha in a meta-analysis of five randomized studies with 400 participants showed a small but significant effect on sleep, more pronounced at a dose of 600 mg daily and when used for eight weeks or longer (Cheah i wsp., PLoS ONE, 2021). Insomnia that persists despite such attempts is a matter for a doctor, not for another preparation.

Frequently Asked Questions

How much melatonin should be taken to shorten the time it takes to fall asleep?

The health claim approved in the European Union states that 1 mg of melatonin should be taken close to bedtime (EFSA, 2011). In Zhdanova's study, a physiological dose of 0.3 mg restored sleep efficiency in people over fifty, while 3 mg induced hypothermia and maintained melatonin levels in the blood until daytime.

When should you choose extended-release melatonin, and when regular?

The regular form has data for falling asleep and jet lag, while the extended-release form has been studied for sleep quality in people over 55 (Lemoine, 2007). In Poland, the latter is Circadin, a prescription medication, so its use is determined by a doctor, not the shelf in the store.

Does melatonin cause dependence?

In a study with 2 mg of extended-release melatonin in 170 people over 55, discontinuation after three weeks did not cause rebound insomnia or withdrawal symptoms (Lemoine, 2007). The data pertains to short-term use, so for longer-term intake, it's advisable to establish a regimen with a doctor.

Czy melatonina pomaga na jet lag?

The Cochrane review included ten studies: in nine, melatonin taken close to the target bedtime reduced jet lag after flying through five or more time zones (Herxheimer and Petrie, 2002). Doses from 0.5 to 5 mg worked similarly, and doses above 5 mg did not work better.

How long before sleep should I take melatonin?

The regular form is taken close to bedtime, and in Zhdanova's study, it was administered 30 minutes before lying down. For Circadin, the product characteristics state 2 mg once a day, 1 to 2 hours before sleep, after a meal. Taking it early in the day delays rhythm adaptation.

Is melatonin from gummies the same as melatonin from the pharmacy?

The molecule is the same, but the legal status is different. A dietary supplement is food and can only use approved claims, such as shortening the time to fall asleep with 1 mg per serving. A medication has a product characteristics and registered indication, and Circadin additionally requires a prescription.

We have gathered other preparations supporting the evening ritual, from herbs to multi-ingredient formulas, in the category supplements.

This article is for informational and educational purposes and does not constitute medical advice. Before starting supplementation, consult your doctor, especially if you are taking medications regularly, are pregnant or breastfeeding, or have a chronic illness.

Author: Michał Waluk · Opublikowano: 2026-06-27 · Aktualizacja: 2026-08-08